Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Autor: Vergori A; Viral Immunodeficiencies Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Matusali G; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Cimini E; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Bordi L; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Borrelli P; Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, University 'G. D'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Lanini S; Viral Immunodeficiencies Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.; Clinica Malattie Infettive, Department of Medicine, University of Udine, 33100 Udine, Italy., Palazzi R; Accettazione e Teleconsulto Rete Regionale Malattie Infettive, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Paulicelli J; Viral Immunodeficiencies Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Mariotti D; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Mazzotta V; Viral Immunodeficiencies Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Notari S; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Casetti R; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Francalancia M; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Rosati S; Emerging Infectious Diseases Unit, National Institute for Infectious Diseases 'L.Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., D'Abramo A; Emerging Infectious Diseases Unit, National Institute for Infectious Diseases 'L.Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Mija C; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Mencarini P; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Milozzi E; Epatology Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Caraffa E; Severe and Immune-Depression Associated Infectious Diseases Unit, National Institute for Infectious Diseases 'Lazzaro Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Sica S; Imaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy., Metafuni E; Imaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy., Sorà F; Imaging Diagnostics Departmenti, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, 00184 Rome, Italy., Rago A; UOSD Ematologia ASL Roma 1, San Filippo Neri Hospital, 00135 Rome, Italy., Siniscalchi A; UOSD Ematologia ASL Roma 1, San Filippo Neri Hospital, 00135 Rome, Italy., Abruzzese E; UOC Ematologia, Sant'Eugenio Hospital, 00144 Rome, Italy., Garzia M; UOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy., Luzi G; UOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy., Battistini R; UOC Ematologia e Trapianto di Cellule Staminali, San Camillo-Forlanini Hospital, 00152 Rome, Italy., Prosperini L; UOC Neurologia e Neurofisiopatologia, San Camillo-Forlanini Hospital, 00152 Rome, Italy., Cingolani A; Infectious Diseases Institute, Policlinico A. Gemelli, 00136 Rome, Italy., Girardi E; Scientific Direction, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, 00184 Rome, Italy., Maggi F; Laboratory of Virology, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy., Antinori A; Viral Immunodeficiencies Unit, National Institute for Infectious Diseases 'L. Spallanzani', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy.; Clinical Department and Research Direction, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, 00184 Rome, Italy.

Publikováno v: Vaccines [Vaccines (Basel)] 2024 Jul 17; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 17.